BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1520354
Paris, I0
Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$48,698,525
-$10,862,044 QoQ
Shares Held
161,773
-10.1% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#85
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. ALNY ranks #14 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,698,525 | 161,773 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $59,560,569 | 180,012 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $43,584,030 | 109,604 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,760,264 | 32,369 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $10,239,878 | 31,402 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $4,275,226 | 15,833 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,835,250 | 12,049 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,477,186 | 5,371 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $1,475,982 | 6,074 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $990,853 | 6,630 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $23,998,794 | 125,379 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $20,035,322 | 113,130 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $19,286,887 | 101,542 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $23,015,765 | 114,895 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $30,145,189 | 126,847 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $13,063,241 | 65,264 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $7,784,159 | 53,371 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $7,246,646 | 44,379 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $213,331 | 1,258 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $10,998,182 | 58,250 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $8,756,555 | 51,655 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $10,682,576 | 75,661 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $7,921,281 | 60,947 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,405,215 | 50,860 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $7,118,610 | 48,063 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $5,919,045 | 54,378 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||